Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
McKinsey
US Army
Baxter
Cerilliant
Farmers Insurance
Medtronic
AstraZeneca
Boehringer Ingelheim

Generated: May 28, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202766

« Back to Dashboard

NDA 202766 describes POLYMYXIN B SULFATE, which is a drug marketed by Aurobindo Pharma Ltd, Fresenius Kabi Usa, Gland Pharma Ltd, West-ward Pharms Int, X Gen Pharms, Xellia Pharms Aps, and Paddock Llc, and is included in seven NDAs. It is available from eight suppliers. Additional details are available on the POLYMYXIN B SULFATE profile page.

The generic ingredient in POLYMYXIN B SULFATE is polymyxin b sulfate. There are twelve drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate profile page.
Summary for 202766
Tradename:POLYMYXIN B SULFATE
Applicant:Xellia Pharms Aps
Ingredient:polymyxin b sulfate
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 202766
Ingredient-typePolymyxins
Medical Subject Heading (MeSH) Categories for 202766
Suppliers and Packaging for NDA: 202766
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
POLYMYXIN B SULFATE polymyxin b sulfate INJECTABLE;INJECTION 202766 ANDA X-GEN Pharmaceuticals, Inc. 39822-0170 N 39822-0170-2
POLYMYXIN B SULFATE polymyxin b sulfate INJECTABLE;INJECTION 202766 ANDA X-GEN Pharmaceuticals, Inc. 39822-0171 N 39822-0171-7

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 500,000 UNITS BASE/VIAL
Approval Date:Jan 15, 2014TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Moodys
Cerilliant
Covington
Boehringer Ingelheim
QuintilesIMS
Cipla
UBS
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.